EV/EBITDA
-16.98
-0.47-2.85%
Wed, 27 Nov 2024 23:30:03 GMT
Summary:
Heron Therapeutics EV/EBITDA is currently -16.98, with a fall of -0.47 (-2.85%) during the most recent trading day. Over the past year, it has dropped by -14.18 (-506.43%). HRTX EV/EBITDA is now -102.35% below its all-time high of 722.88.HRTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HRTX EV/EBITDA Performance
PeriodPeriod | EV/EBITDAEV/EBITDA |
---|---|
todaytoday | -2.9% |
1 m1 month | +23.8% |
3 m3 months | -51.3% |
6 m6 months | -83.0% |
ytdytd | -331.0% |
1 y1 year | -506.4% |
5 y5 years | -45.4% |
HRTX EV/EBITDA High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | -16.43 | -3.4% | -23.11 | +26.5% |
3 m | 3 months | -10.76 | -57.8% | -24.32 | +30.2% |
6 m | 6 months | -8.48 | -100.2% | -24.32 | +30.2% |
1 y | 1 year | -2.68 | -533.6% | -24.32 | +30.2% |
3 y | 3 years | -1.49 | -1039.6% | -24.32 | +30.2% |
5 y | 5 years | -1.49 | -1039.6% | -24.32 | +30.2% |
alltime | all time | 722.88 | -102.3% | -353.43 | +95.2% |
Heron Therapeutics EV/EBITDA History
Date | Value |
---|---|
2024 | -16.98(+331.0%) |
2023 | -3.94(+58.2%) |
2022 | -2.49(-46.5%) |
2021 | -4.65(-44.1%) |
2020 | -8.32(-19.1%) |
2019 | -10.29(-10.1%) |
2018 | -11.45(+108.6%) |
2017 | -5.49(+67.4%) |
2016 | -3.28(-64.7%) |
2015 | -9.29(+211.7%) |
2014 | -2.98(+14.6%) |
2013 | -2.60(-45.7%) |
2012 | -4.79(+84.9%) |
2011 | -2.59(+13.1%) |
2010 | -2.29(-47.0%) |
2009 | -4.32(+3223.1%) |
2008 | -0.13(-80.3%) |
2007 | -0.66(-62.3%) |
2006 | -1.75(-63.3%) |
Date | Value |
---|---|
2005 | -4.77(+8.4%) |
2004 | -4.40(-48.1%) |
2003 | -8.47(+130.8%) |
2002 | -3.67(-49.6%) |
2001 | -7.28(-23.2%) |
2000 | -9.48(-102.2%) |
1999 | 440.75(-638.2%) |
1998 | -81.89(-34.9%) |
1997 | -125.85(+530.5%) |
1996 | -19.96(+53.9%) |
1995 | -12.97(+50.5%) |
1994 | -8.62(+10.2%) |
1993 | -7.82(-62.3%) |
1992 | -20.76(-36.2%) |
1991 | -32.55(+434.5%) |
1990 | -6.09(-72.4%) |
1989 | -22.04(+174.8%) |
1988 | -8.02(-5.9%) |
1987 | -8.52 |
FAQ
- What is Heron Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Heron Therapeutics?
- What is HRTX EV/EBITDA year-to-date change?
- What is Heron Therapeutics EV/EBITDA year-on-year change?
What is Heron Therapeutics EV/EBITDA?
The current EV/EBITDA of HRTX is -16.98
What is the all time high EV/EBITDA for Heron Therapeutics?
Heron Therapeutics all-time high EV/EBITDA is 722.88
What is HRTX EV/EBITDA year-to-date change?
Heron Therapeutics EV/EBITDA has changed by -13.04 (-330.96%) since the beginning of the year
What is Heron Therapeutics EV/EBITDA year-on-year change?
Over the past year, HRTX EV/EBITDA has changed by -14.18 (-506.43%)